Axogen (AXGN) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.50% |
| Dec 31, 2025 | 51.63% |
| Sep 30, 2025 | -26.49% |
| Jun 30, 2025 | 19.87% |
| Mar 31, 2025 | -2.76% |
| Dec 31, 2024 | 31.07% |
| Sep 30, 2024 | 18.45% |
| Jun 30, 2024 | 22.54% |
| Mar 31, 2024 | -6.46% |
| Dec 31, 2023 | -20.51% |
| Sep 30, 2023 | 18.23% |
| Jun 30, 2023 | 21.39% |
| Mar 31, 2023 | -13.58% |
| Dec 31, 2022 | -27.89% |
| Sep 30, 2022 | -15.98% |
| Jun 30, 2022 | -32.97% |
| Mar 31, 2022 | -31.75% |
| Dec 31, 2021 | -11.01% |
| Sep 30, 2021 | 41.08% |
| Jun 30, 2021 | -24.49% |
| Mar 31, 2021 | -22.66% |
| Dec 31, 2020 | -34.28% |
| Sep 30, 2020 | 46.91% |
| Jun 30, 2020 | -35.48% |
| Mar 31, 2020 | -36.00% |
| Dec 31, 2019 | -10.42% |
| Sep 30, 2019 | -16.09% |
| Jun 30, 2019 | -17.29% |
| Mar 31, 2019 | -22.80% |
| Dec 31, 2018 | -15.84% |
| Sep 30, 2018 | -23.44% |
| Jun 30, 2018 | -11.53% |
| Mar 31, 2018 | -18.30% |
| Dec 31, 2017 | 14.60% |
| Sep 30, 2017 | -5.67% |
| Jun 30, 2017 | -18.85% |
| Mar 31, 2017 | -10.08% |
| Dec 31, 2016 | 16.86% |
| Sep 30, 2016 | -0.84% |
| Jun 30, 2016 | -16.90% |
| Mar 31, 2016 | -34.07% |
| Dec 31, 2015 | -41.97% |
| Sep 30, 2015 | -16.92% |